CN102791727A - 用于检测莱姆病抗体的肽和方法 - Google Patents

用于检测莱姆病抗体的肽和方法 Download PDF

Info

Publication number
CN102791727A
CN102791727A CN2010800616653A CN201080061665A CN102791727A CN 102791727 A CN102791727 A CN 102791727A CN 2010800616653 A CN2010800616653 A CN 2010800616653A CN 201080061665 A CN201080061665 A CN 201080061665A CN 102791727 A CN102791727 A CN 102791727A
Authority
CN
China
Prior art keywords
amino acid
acid selected
peptide
sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800616653A
Other languages
English (en)
Chinese (zh)
Inventor
R·K·梅拉
K·P·阿伦
D·M·布莱利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Love Bass Limited-Liability Co
Original Assignee
Love Bass Limited-Liability Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Love Bass Limited-Liability Co filed Critical Love Bass Limited-Liability Co
Publication of CN102791727A publication Critical patent/CN102791727A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
CN2010800616653A 2009-11-17 2010-11-17 用于检测莱姆病抗体的肽和方法 Pending CN102791727A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26209909P 2009-11-17 2009-11-17
US61/262,099 2009-11-17
PCT/US2010/057053 WO2011063003A2 (en) 2009-11-17 2010-11-17 Peptides and methods for the detection of lyme disease antibodies

Publications (1)

Publication Number Publication Date
CN102791727A true CN102791727A (zh) 2012-11-21

Family

ID=44060312

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800616653A Pending CN102791727A (zh) 2009-11-17 2010-11-17 用于检测莱姆病抗体的肽和方法

Country Status (8)

Country Link
US (1) US8568989B2 (enExample)
EP (1) EP2501719B1 (enExample)
JP (1) JP2013511530A (enExample)
KR (1) KR20120096932A (enExample)
CN (1) CN102791727A (enExample)
AU (1) AU2010322085B2 (enExample)
CA (1) CA2781110C (enExample)
WO (1) WO2011063003A2 (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104330555A (zh) * 2014-10-22 2015-02-04 中国检验检疫科学研究院 检测伯氏疏螺旋体抗体的试纸、试纸制备方法及试剂盒
CN105548577A (zh) * 2016-02-04 2016-05-04 安徽医科大学 一种琥珀酰-β-环糊精修饰的莱姆病检测用蛋白质芯片及其制备与应用
CN106397589A (zh) * 2016-10-31 2017-02-15 杭州贝英福生物科技有限公司 一种狭义伯氏疏螺旋体多克隆抗体及应用
CN106432487A (zh) * 2016-10-31 2017-02-22 杭州贝英福生物科技有限公司 一种伽氏疏螺旋体多克隆抗体及应用
CN108351355A (zh) * 2015-08-27 2018-07-31 奎多公司 具有两个流体流动路径用于检测和区分两个或多个分析物的免疫分析测试设备
CN109564220A (zh) * 2016-06-03 2019-04-02 泰兹特有限公司 用于检测生物样品中蜱传微生物的方法和固体支持物

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
RS58168B1 (sr) * 2011-11-21 2019-03-29 Abay Sa Imunološko ispitivanje pojačavanjem signala
JP2013164414A (ja) * 2012-01-13 2013-08-22 Nippon Meat Packers Inc 抗菌ペプチドを用いた微生物の検出方法及び検出用キット
US9194870B2 (en) 2014-01-21 2015-11-24 Abaxis, Inc. Peptides, devices, and methods for the detection of Anaplasma antibodies
US20150293086A1 (en) * 2014-04-14 2015-10-15 Abreos Biosciences, Inc. Lateral flow immunoassay
TWI691716B (zh) 2014-08-13 2020-04-21 美商艾巴希斯公司 電漿特異性結合搭配物檢定中之信號放大
US11061028B2 (en) * 2014-09-24 2021-07-13 Defined Diagnostics, Llc Compositions and methods for the diagnosis of lyme disease
CA2991532C (en) 2015-08-04 2024-03-05 Abaxis, Inc. Signal amplification in solution-based plasmonic specific-binding partner assays
USD800912S1 (en) 2016-06-17 2017-10-24 Abreos Biosciences, Inc. Point-of-care diagnostic device
US11680948B2 (en) 2016-08-12 2023-06-20 Abreos Biosciences, Inc. Detection and quantification of natalizumab
MX2019008970A (es) 2017-01-30 2019-12-19 Abay Sa Ensayos de socio de unión específico de plasmón basados en solución y nanoestructuras metálicas.
JP7062803B1 (ja) * 2021-03-31 2022-05-06 積水メディカル株式会社 抗薬物抗体測定方法
EP4220166A1 (en) 2022-02-01 2023-08-02 Universitat Rovira I Virgili (URV) In vitro method for detecting antibodies in a sample
WO2023196781A1 (en) * 2022-04-04 2023-10-12 Antigen Discovery Inc. Antigens for detection of early lyme disease

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US4888276A (en) 1986-06-26 1989-12-19 Minnesota Mining And Manufacturing Company Method and composition for the diagnosis of Lyme disease
US4721617A (en) 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease
US5385826A (en) 1989-04-21 1995-01-31 Gundersen Medical Foundation, Ltd. Diagnostic assay for lyme disease
DE4015911A1 (de) 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
US5187065A (en) 1989-12-22 1993-02-16 Schutzer Steven E Method and materials for detecting lyme disease
EP0536335A4 (en) 1990-06-15 1993-07-14 Yale University Compositions and methods for the prevention and diagnosis of lyme disease
US5155022A (en) 1991-02-08 1992-10-13 Becton, Dickinson And Company Assay for lyme disease
US5324630A (en) 1991-06-28 1994-06-28 The Regents Of The University Of California Methods and compositions for diagnosing lyme disease
US6221363B1 (en) 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
WO1993003184A1 (en) 1991-08-09 1993-02-18 Mccann Associates, Inc. Method for detecting lyme disease and composition
US5965702A (en) 1991-10-21 1999-10-12 Abbott Laboratories Borrelia burgdorferi antigens and uses thereof
US5618533A (en) 1992-02-11 1997-04-08 Yale University Flagellin-based polypeptides for the diagnosis of lyme disease
US5308753A (en) 1992-02-20 1994-05-03 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods for purifying and detecting IGM antibodies
US5620862A (en) 1993-11-24 1997-04-15 University Of Connecticut Methods for diagnosing early Lyme disease
US5932220A (en) 1995-05-08 1999-08-03 Board Of Regents University Of Texas System Diagnostic tests for a new spirochete, Borrelia lonestari sp. nov.
DE69733944T3 (de) 1996-02-21 2012-07-26 The Board Of Regents, The University Of Texas System Vmp-ähnliche sequenzen von pathogener borrelia
US6716574B2 (en) 1996-05-02 2004-04-06 Dako A/S Osp-C derived peptide fragments
US6902893B1 (en) 1997-06-20 2005-06-07 Gil H. Choi Lyme disease vaccines
CA2294701C (en) 1997-06-30 2009-09-08 The Administrators Of The Tulane Educational Fund Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
CA2365424A1 (en) 1999-04-21 2000-10-26 Boston Medical Center Corporation Prevention, diagnosis and treatment of lyme disease
US6475492B1 (en) 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease
US6665652B1 (en) 1999-07-28 2003-12-16 Richard B. Porwancher Method of diagnosis of lyme disease
AU2002259117A1 (en) * 2001-05-03 2002-11-18 Immunetics, Inc. Systems and methods for detection of analytes in biological fluids
US6838247B2 (en) 2002-06-19 2005-01-04 Bowen Research And Training Test for lyme disease
US7847084B2 (en) 2002-12-20 2010-12-07 Board Of Regents, The University Of Texas System VMP-like sequences of pathogenic Borrelia species and strains
US20060046310A1 (en) 2004-08-25 2006-03-02 Zong-Li Xia Amplification method for solid phase immunoassays
US7390626B2 (en) 2005-02-25 2008-06-24 Immunosciences Lab., Inc. Methods and kit for diagnosing tick borne illnesses
EP1869468B1 (en) 2005-03-29 2010-05-05 Inverness Medical Switzerland GmbH Colloidal metal conjugates
WO2007133623A2 (en) 2006-05-10 2007-11-22 Biopeptides Corporation Peptide diagnostic agent for lyme disease
US7776618B2 (en) 2007-03-01 2010-08-17 Church & Dwight Co., Inc. Diagnostic detection device
US8399261B2 (en) 2007-06-27 2013-03-19 Inbios International, Inc. Lateral flow assay system and methods for its use
EP2058663A1 (en) 2007-11-12 2009-05-13 Euro-Diagnostica B.V. Method for the immobilization of an analyte on a solid support
JP2009236685A (ja) 2008-03-27 2009-10-15 Sysmex Corp クロマトグラフィー用試験具

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104330555A (zh) * 2014-10-22 2015-02-04 中国检验检疫科学研究院 检测伯氏疏螺旋体抗体的试纸、试纸制备方法及试剂盒
CN104330555B (zh) * 2014-10-22 2016-05-11 中国检验检疫科学研究院 检测伯氏疏螺旋体抗体的试纸、试纸制备方法及试剂盒
CN108351355A (zh) * 2015-08-27 2018-07-31 奎多公司 具有两个流体流动路径用于检测和区分两个或多个分析物的免疫分析测试设备
CN113740533A (zh) * 2015-08-27 2021-12-03 奎多公司 具有两个流体流动路径用于检测和区分两个或多个分析物的免疫分析测试设备
CN105548577A (zh) * 2016-02-04 2016-05-04 安徽医科大学 一种琥珀酰-β-环糊精修饰的莱姆病检测用蛋白质芯片及其制备与应用
CN105548577B (zh) * 2016-02-04 2017-09-19 安徽医科大学 一种琥珀酰‑β‑环糊精修饰的莱姆病检测用蛋白质芯片及其制备与应用
CN109564220A (zh) * 2016-06-03 2019-04-02 泰兹特有限公司 用于检测生物样品中蜱传微生物的方法和固体支持物
US11353455B2 (en) 2016-06-03 2022-06-07 Te?Ted Oy Method and a solid support for detecting tick-borne microbes in a biological sample
CN106397589A (zh) * 2016-10-31 2017-02-15 杭州贝英福生物科技有限公司 一种狭义伯氏疏螺旋体多克隆抗体及应用
CN106432487A (zh) * 2016-10-31 2017-02-22 杭州贝英福生物科技有限公司 一种伽氏疏螺旋体多克隆抗体及应用

Also Published As

Publication number Publication date
KR20120096932A (ko) 2012-08-31
WO2011063003A3 (en) 2011-09-01
EP2501719A2 (en) 2012-09-26
US20110136155A1 (en) 2011-06-09
EP2501719A4 (en) 2013-07-31
JP2013511530A (ja) 2013-04-04
AU2010322085A1 (en) 2012-07-05
CA2781110A1 (en) 2011-05-26
CA2781110C (en) 2018-07-31
AU2010322085B2 (en) 2016-09-15
WO2011063003A2 (en) 2011-05-26
EP2501719B1 (en) 2015-11-04
US8568989B2 (en) 2013-10-29

Similar Documents

Publication Publication Date Title
US11573227B2 (en) Peptides and methods for the detection of Lyme disease antibodies
US8568989B2 (en) Peptides and methods for the detection of Lyme disease antibodies
CN102834411B (zh) 用于检测埃里希体属抗体的肽、装置和方法
CN105051541B (zh) 用于检测埃里希体属抗体的肽、装置和方法
CN105916518A (zh) 用于无形体属抗体的检测的肽、装置和方法
HK40102336A (en) Peptides and methods for the detection of lyme disease antibodies
HK40010384A (en) Peptides and methods for the detection of lyme disease antibodies
HK40010384B (en) Peptides and methods for the detection of lyme disease antibodies

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20121121